Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUNLUN ENERGY
00135
5
CHINA OILFIELD
02883
CN Stock MarketDetailed Quotes
Shijiazhuang Yiling Pharmaceutical (002603)
- 16.76
- +0.09+0.54%
Not Open Apr 27 15:00 CST
28.00BMarket Cap20.44P/E (TTM)
16.79High16.47Low136.15KlotVolume16.55Open16.67Prev Close226.76MTurnover0.99%Turnover Ratio21.77P/E (Static)1.67BShares21.5852wk High2.46P/B23.07BFloat Cap13.3552wk Low18.34Limit Up1.38BShs Float52.86Historical High15.00Limit Down1.92%Range %4.49Historical Low0.30Dividend TTM16.65Avg Price74.16KlotAsk1.79%Div Yield TTM100Lot Size60.00KlotBid
Shijiazhuang Yiling Pharmaceutical (002603) Balance Sheet
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -21.85%783.99M | 29.53%1.1B | 14.01%1.03B | -15.00%1.04B | -15.68%1B | -9.30%853.03M | -15.41%907.31M | -30.28%1.22B | 14.88%1.19B | -50.61%940.51M |
| Transactional financial assets | 909.35%1.65B | --764.42M | 10,016.67%910.5M | --560.5M | 43.73%163M | ---- | -96.19%9M | ---- | -91.87%113.4M | -60.27%205.97M |
| Notes receivable and accounts receivable | -19.22%1.3B | 0.28%1.23B | -50.32%1.38B | -49.09%1.4B | -37.29%1.61B | -49.05%1.23B | 11.67%2.78B | 22.17%2.75B | 32.22%2.56B | 39.29%2.41B |
| -Notes receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --4M |
| -Accounts receivable | -19.22%1.3B | 0.28%1.23B | -50.32%1.38B | -49.09%1.4B | -37.29%1.61B | -48.97%1.23B | 11.67%2.78B | 22.17%2.75B | 32.22%2.56B | 39.05%2.4B |
| Other receivables (including interest and dividends) | -1.02%18.36M | -87.61%16.09M | -27.44%18.97M | 71.56%17.75M | 213.39%18.55M | 2,325.55%129.85M | 299.75%26.15M | 63.31%10.35M | -5.78%5.92M | -3.88%5.35M |
| -Other receivable | ---- | -87.61%16.09M | ---- | 71.56%17.75M | ---- | 2,325.55%129.85M | ---- | 63.31%10.35M | ---- | -3.88%5.35M |
| Advance payment | -37.06%60.19M | 34.21%70.83M | -47.62%77.71M | -50.63%69.04M | -14.82%95.63M | -51.90%52.77M | -36.56%148.35M | -34.24%139.82M | -61.76%112.27M | -78.75%109.71M |
| Inventories | -2.95%1.34B | -14.76%1.49B | -13.18%1.69B | -23.45%1.47B | -30.75%1.39B | -28.97%1.75B | -20.02%1.94B | -23.68%1.92B | -29.10%2B | 21.61%2.46B |
| Receivable financing | 22.33%566.83M | 155.08%420.06M | 21.04%374.36M | 54.74%556.23M | -15.11%463.37M | -13.89%164.68M | 87.34%309.28M | 91.14%359.46M | -29.08%545.87M | -57.58%191.24M |
| Other current assets | 17.91%68.04M | -30.94%112.43M | -9.19%58.34M | -58.65%56.51M | -53.86%57.71M | -28.31%162.81M | -67.24%64.25M | 7.70%136.65M | -36.94%125.07M | 106.18%227.08M |
| Total current assets | 20.68%5.79B | 20.10%5.21B | -10.41%5.54B | -20.95%5.17B | -27.97%4.79B | -33.75%4.33B | -9.40%6.18B | -12.33%6.54B | -21.32%6.66B | -9.79%6.54B |
| Non Current assets | ||||||||||
| Other non-current financial assets | ---- | ---- | ---- | ---- | ---- | -99.94%1M | -15.74%1.65B | -19.91%1.64B | -11.82%1.62B | 22.42%1.65B |
| Investment real estate | 16.27%70.55M | 13.57%71.04M | 137.01%55.37M | 136.33%56.36M | 214.51%60.68M | 152.02%62.56M | -12.89%23.36M | 5.81%23.85M | -16.99%19.29M | 6.32%24.82M |
| Long-term equity investment | -0.43%2.46M | -0.43%2.46M | -0.46%2.46M | -0.42%2.47M | -0.46%2.47M | -0.46%2.47M | -0.54%2.47M | -0.46%2.48M | -0.72%2.48M | -0.60%2.48M |
| Fixed assets | ---- | 0.08%6.02B | ---- | -3.03%5.76B | ---- | 3.39%6.01B | ---- | 9.60%5.94B | ---- | 25.72%5.81B |
| Constru in process | ---- | -25.59%890.66M | ---- | -4.59%1.28B | ---- | -18.61%1.2B | ---- | -14.42%1.34B | ---- | -6.59%1.47B |
| Productive biological assets | -73.37%4.6M | -27.45%11.7M | 388.92%22.87M | 219.50%19.22M | 217.36%17.28M | 190.36%16.13M | -44.61%4.68M | -18.29%6.01M | -29.22%5.44M | -26.17%5.55M |
| Intangible assets | -1.38%784.51M | -1.33%791.87M | 8.89%785.32M | 8.75%792.47M | 8.03%795.47M | 7.94%802.57M | -4.02%721.23M | -3.93%728.74M | 2.60%736.34M | 2.69%743.52M |
| Development expenditure | 0.21%270.71M | -3.48%253.64M | 49.10%323.17M | 48.70%298.79M | 40.81%270.13M | 41.70%262.8M | 37.73%216.74M | 65.53%200.94M | 72.91%191.84M | 78.43%185.47M |
| Goodwill | -5.78%101.72M | -5.69%103.28M | -5.62%104.83M | -5.54%106.39M | -5.46%107.95M | -5.39%109.51M | -2.77%111.07M | -1.41%112.63M | --114.19M | --115.75M |
| Long deferred expense | 39.39%6.23M | 58.90%6.48M | -30.70%3.26M | -3.73%3.03M | 31.06%4.47M | 4.62%4.08M | 80.65%4.71M | 11.99%3.15M | 12.99%3.41M | 21.07%3.9M |
| Deferred tax assets | -39.84%231.72M | -40.31%218.35M | 108.58%307.69M | 87.57%307.48M | 118.39%385.17M | 99.28%365.84M | 24.95%147.52M | -1.28%163.93M | -31.27%176.37M | -35.46%183.58M |
| Usufruct assets | 0.08%26.75M | 1.71%28.47M | 35.80%32.3M | 35.80%34.45M | 38.10%26.72M | 36.30%27.99M | 30.43%23.78M | 27.00%25.37M | -6.20%19.35M | -8.23%20.53M |
| Other non current assets | -42.28%74.16M | -38.11%74.79M | -61.95%82.28M | -68.76%69.89M | -54.10%128.48M | -44.20%120.84M | -54.44%216.27M | -49.64%223.69M | -40.40%279.92M | -41.36%216.57M |
| Total non current assets | -5.70%8.39B | -5.74%8.47B | -16.78%8.68B | -16.16%8.73B | -15.02%8.9B | -13.91%8.98B | -1.69%10.43B | -2.64%10.41B | 7.00%10.47B | 14.85%10.44B |
| Total assets | 3.53%14.18B | 2.67%13.67B | -14.41%14.22B | -18.01%13.9B | -20.05%13.69B | -21.56%13.32B | -4.71%16.61B | -6.62%16.95B | -6.13%17.13B | 3.91%16.98B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | ---- | ---- | ---- | ---- | ---- | ---- | -33.34%600.29M | -54.00%460.26M | -14.28%600.36M | 19.99%600.35M |
| Notes payable and accounts payable | -20.78%1.5B | -22.58%1.47B | -29.12%1.81B | -30.80%1.77B | -30.19%1.89B | -33.37%1.9B | 10.48%2.55B | -10.76%2.55B | -2.77%2.71B | 38.13%2.85B |
| -Notes payable | ---- | ---- | -98.79%7.19M | -86.78%83.26M | -83.34%126.07M | -93.08%50M | 40.74%592.56M | 11.65%629.84M | 20.12%756.69M | 24.42%722.79M |
| -Accounts payable | -15.13%1.5B | -20.49%1.47B | -8.01%1.8B | -12.46%1.68B | -9.62%1.77B | -13.05%1.85B | 3.72%1.96B | -16.27%1.92B | -9.45%1.95B | 43.51%2.12B |
| Contract liabilities | 19.91%431.98M | 12.27%305.76M | 97.15%342.08M | 49.97%409.21M | 6.86%360.26M | -5.28%272.34M | -18.42%173.51M | -35.19%272.85M | -71.78%337.12M | -74.00%287.52M |
| Advance receipts | --219.6K | --259.74K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Salaries payable | -6.94%231.81M | -8.62%258.82M | -11.24%182.91M | -14.13%201.57M | -0.25%249.09M | 0.74%283.23M | -12.59%206.08M | -11.72%234.74M | -18.78%249.71M | -25.97%281.15M |
| Taxs payable | -7.66%80.28M | 35.07%103.17M | 21.25%109.28M | -14.39%89.25M | -37.29%86.94M | -55.04%76.38M | -49.94%90.13M | -31.99%104.25M | -52.40%138.65M | -64.16%169.89M |
| Other payable (including interest and dividends) | 0.36%44.94M | 9.31%52.99M | 77.36%543.31M | -92.34%41M | 40.39%44.78M | 12.21%48.48M | -42.65%306.33M | -41.83%535.54M | -63.62%31.9M | -64.09%43.2M |
| -Dividend payable | ---- | ---- | 82.87%501.21M | ---- | ---- | ---- | -39.34%274.08M | -39.64%501.21M | ---- | ---- |
| -Other payable | ---- | 9.31%52.99M | ---- | 19.45%41M | ---- | 12.21%48.48M | ---- | -61.96%34.32M | ---- | -64.09%43.2M |
| Non current liabilities due within one year | 51.27%11.74M | 17.68%9.69M | 226.68%9.85M | -95.21%9.75M | -96.18%7.76M | -96.01%8.24M | -31.57%3.02M | 3,741.99%203.69M | 30.94%203.05M | 32.46%206.62M |
| Other current liabilities | -38.03%12.21M | -56.92%9.24M | -31.17%7.12M | -12.67%9.23M | 45.55%19.7M | 87.69%21.45M | -42.70%10.34M | -14.92%10.57M | -64.06%13.54M | -78.53%11.43M |
| Total current liabilities | -13.10%2.31B | -15.29%2.21B | -23.80%3B | -42.25%2.53B | -37.90%2.66B | -41.38%2.61B | -10.34%3.94B | -22.43%4.37B | -22.96%4.29B | -8.32%4.45B |
| Current liabilities | ||||||||||
| Long term loan | ---- | ---- | ---- | ---- | ---- | ---- | -4.75%667.1M | 99.36%598.4M | 199.16%598.73M | 199.33%599.1M |
| Deferred tax liabilities | -4.63%107.47M | -4.50%109.11M | -13.05%110.68M | -12.80%112.39M | -13.66%112.69M | -12.21%114.25M | 1.26%127.3M | 3.33%128.89M | 1,718.48%130.53M | 1,171.38%130.14M |
| Long term deferred income | -5.21%355.42M | -4.81%359.75M | 4.08%390.92M | 1.86%371.48M | 4.47%374.96M | 7.25%377.92M | 5.44%375.59M | -3.72%364.69M | 8.49%358.93M | 5.18%352.37M |
| Lease liabilities | -38.71%11.7M | -11.91%16.04M | -1.05%20.48M | 0.22%21.8M | 28.74%19.09M | 39.94%18.21M | 63.43%20.69M | 63.85%21.75M | 5.62%14.83M | -13.08%13.01M |
| Total non current liabilities | -6.34%474.59M | -4.99%484.9M | -56.15%522.08M | -54.60%505.67M | -54.06%506.74M | -53.37%510.39M | -0.36%1.19B | 36.33%1.11B | 99.75%1.1B | 95.34%1.09B |
| Total liabilities | -12.02%2.79B | -13.60%2.69B | -31.31%3.52B | -44.75%3.03B | -41.21%3.17B | -43.75%3.12B | -8.21%5.13B | -15.00%5.49B | -11.87%5.39B | 2.42%5.54B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B | 0.00%1.67B |
| Capital reserve funds | -0.81%2.32B | -0.81%2.32B | -0.81%2.32B | -0.81%2.32B | 0.00%2.34B | 0.00%2.34B | 0.00%2.34B | 0.00%2.34B | 0.00%2.34B | 0.00%2.34B |
| Surplus reserve funds | 0.00%936.76M | 0.00%936.76M | 0.00%936.76M | 0.00%936.76M | 0.00%936.76M | 0.00%936.76M | -0.00%936.76M | -0.00%936.76M | -0.00%936.76M | 0.00%936.76M |
| Retained profit | 15.49%6.47B | 14.87%6.07B | -11.89%5.78B | -8.97%5.95B | -17.68%5.61B | -18.84%5.28B | -5.10%6.56B | -3.32%6.54B | -5.31%6.81B | 8.63%6.51B |
| Other composite income | -3.85%-7.45M | -10.03%-7.83M | -15.89%-7.02M | -9.77%-7.24M | -7.96%-7.18M | -7.67%-7.12M | 4.15%-6.06M | -5.92%-6.59M | 3.31%-6.65M | 8.38%-6.61M |
| Shareholders equity without minority interests | 8.05%11.4B | 7.49%10.99B | -6.95%10.7B | -5.28%10.87B | -10.25%10.55B | -10.71%10.22B | -2.97%11.5B | -1.92%11.48B | -3.14%11.75B | 4.73%11.45B |
| Minority interests | 67.91%-7.44M | 66.32%-7.21M | 66.00%-6.19M | 63.40%-5.69M | -68.85%-23.19M | -82.44%-21.4M | -116.68%-18.2M | -134.97%-15.56M | -354.34%-13.74M | -502.77%-11.73M |
| Total shareholder equity | 8.21%11.39B | 7.64%10.98B | -6.86%10.7B | -5.20%10.87B | -10.34%10.53B | -10.81%10.2B | -3.06%11.49B | -2.00%11.46B | -3.23%11.74B | 4.65%11.44B |
| Total liabilityies and equity | 3.53%14.18B | 2.67%13.67B | -14.41%14.22B | -18.01%13.9B | -20.05%13.69B | -21.56%13.32B | -4.71%16.61B | -6.62%16.95B | -6.13%17.13B | 3.91%16.98B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Zhongqin Wanxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongqin Wanxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongqin Wanxin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm